Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus modified-release (MR4) conversion in stable kidney transplant recipients
2006-000937-37Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of retigabine in Kidney allograft status (RTx), sponsored by Astellas Pharma. Started Jun 2006; status: completed.
02
Drugs
retigabine
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2006-000937-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000937-37.